BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26120931)

  • 1. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
    Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
    J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry.
    Wu HY; Pan YY; Kopylov AT; Zgoda V; Ma MC; Wang CH; Su WC; Lai WW; Cheng PN; Liao PC
    Proteomics Clin Appl; 2020 Jul; 14(4):e1900095. PubMed ID: 32012456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion.
    Chen CD; Wang CL; Yu CJ; Chien KY; Chen YT; Chen MC; Chang YS; Wu CC; Yu JS
    J Proteome Res; 2014 Jun; 13(6):2818-29. PubMed ID: 24787432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera.
    Sung HJ; Jeon SA; Ahn JM; Seul KJ; Kim JY; Lee JY; Yoo JS; Lee SY; Kim H; Cho JY
    J Proteomics; 2012 Apr; 75(7):2170-80. PubMed ID: 22300576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
    Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
    Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
    J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
    Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
    J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.
    Quon BS; Dai DL; Hollander Z; Ng RT; Tebbutt SJ; Man SF; Wilcox PG; Sin DD
    Thorax; 2016 Mar; 71(3):216-22. PubMed ID: 25777587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a reliable multiple reaction monitoring-based method for the quantification of obesity-associated comorbidities in serum and adipose tissue requires intensive clinical validation.
    Oberbach A; Schlichting N; Neuhaus J; Kullnick Y; Lehmann S; Heinrich M; Dietrich A; Mohr FW; von Bergen M; Baumann S
    J Proteome Res; 2014 Dec; 13(12):5784-800. PubMed ID: 25318410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
    Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
    Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.
    Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X
    Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.
    Shin J; Song SY; Ahn HS; An BC; Choi YD; Yang EG; Na KJ; Lee ST; Park JI; Kim SY; Lee C; Lee SW
    PLoS One; 2017; 12(8):e0183896. PubMed ID: 28837649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
    Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
    J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
    Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
    Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
    Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative targeted screening of proteins associated with lung adenocarcinoma cancer by the method of selected reaction monitoring].
    Kopylov AT; Tikhonova OV; Farafonova TE; Novikova SE; Shushkova NA; Shevchenko VE; Liao PC; Archakov AI; Zgoda VG
    Biomed Khim; 2018 Aug; 64(4):368-375. PubMed ID: 30135285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Novel Plasma Protein Signature for Breast Cancer Diagnosis by Using Multiple Reaction Monitoring-based Mass Spectrometry.
    Lee HB; Kang UB; Moon HG; Lee J; Lee KM; Yi M; Park YS; Lee JW; Yu JH; Choi SH; Cho SH; Lee C; Han W; Noh DY
    Anticancer Res; 2015 Nov; 35(11):6271-9. PubMed ID: 26504062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.